Gastrointestinal (GI), liver, and pancreatic diseases are significant contributors to morbidity, mortality, and healthcare costs in the United States. This study analyzed data from national databases to estimate the burden and cost of these diseases. The findings reveal that in 2012, there were 7 million diagnoses of gastroesophageal reflux disease (GERD) and nearly 4 million diagnoses of hemorrhoids in outpatient settings. Functional and motility disorders led to nearly 1 million emergency department visits, most for constipation. GI hemorrhage was the most common diagnosis leading to hospitalization, with over 500,000 discharges at a cost of nearly $5 billion. Hospitalizations for inflammatory bowel disease, Clostridium difficile infection, and chronic liver disease have increased over the past 20 years. In 2011, over 1 million people in the US lived with colorectal cancer, which was the leading cause of GI-related death, followed by pancreatic and hepatobiliary neoplasms. The study highlights the substantial burden of GI and liver diseases in the US, emphasizing the need for continued research and public health efforts. The data show that these diseases result in significant healthcare utilization and costs. The report also notes that the US population is aging, increasing the risk of chronic hepatitis C and liver diseases. Despite advances in treatment, hospitalizations for inflammatory bowel disease have increased, indicating a growing burden. The study underscores the importance of screening and early detection in reducing colorectal cancer incidence and mortality. The findings suggest that the burden of these diseases will continue to rise, necessitating further research and public health interventions. The study provides a comprehensive overview of the current state of GI and liver diseases in the US, highlighting the need for continued attention to these conditions.Gastrointestinal (GI), liver, and pancreatic diseases are significant contributors to morbidity, mortality, and healthcare costs in the United States. This study analyzed data from national databases to estimate the burden and cost of these diseases. The findings reveal that in 2012, there were 7 million diagnoses of gastroesophageal reflux disease (GERD) and nearly 4 million diagnoses of hemorrhoids in outpatient settings. Functional and motility disorders led to nearly 1 million emergency department visits, most for constipation. GI hemorrhage was the most common diagnosis leading to hospitalization, with over 500,000 discharges at a cost of nearly $5 billion. Hospitalizations for inflammatory bowel disease, Clostridium difficile infection, and chronic liver disease have increased over the past 20 years. In 2011, over 1 million people in the US lived with colorectal cancer, which was the leading cause of GI-related death, followed by pancreatic and hepatobiliary neoplasms. The study highlights the substantial burden of GI and liver diseases in the US, emphasizing the need for continued research and public health efforts. The data show that these diseases result in significant healthcare utilization and costs. The report also notes that the US population is aging, increasing the risk of chronic hepatitis C and liver diseases. Despite advances in treatment, hospitalizations for inflammatory bowel disease have increased, indicating a growing burden. The study underscores the importance of screening and early detection in reducing colorectal cancer incidence and mortality. The findings suggest that the burden of these diseases will continue to rise, necessitating further research and public health interventions. The study provides a comprehensive overview of the current state of GI and liver diseases in the US, highlighting the need for continued attention to these conditions.